Advertisement
Screener

CEL-SCI CORPORATION (CVM) Cash Flow Breakdown

CEL-SCI CORPORATION Cash Flow Breakdown

Cash flow breakdown shows where CEL-SCI CORPORATION's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-09-30: from running the business, $17.12M went out.
  • Fiscal year ended 2025-09-30: from investing, $38.11K went out.
  • Fiscal year ended 2025-09-30: from financing, $23.37M came in.
  • Fiscal year ended 2025-09-30: change in cash, $6.22M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew shares soldNot split outChange in cash
2025-09-30-$17.12M-$38.11K$28.29M-$4.92M*$6.22M
2024-09-30-$18.81M-$108.09K$23.57M-$4.06M*$592.44K
2023-09-30-$22.85M-$372.26K$6.55M-$1.86M*-$18.53M
2022-09-30-$18.24M$5.49M$29.84K-$668.26K*-$13.39M
2021-09-30-$18.79M-$15.18M$47.36M$7.16M*$20.55M
2020-09-30-$15.28M-$2.69M$13.99M$11.04M*$7.06M
2019-09-30-$16.32M-$335.84K$0.00$14.79M*-$1.87M
2018-09-30-$13.39M-$58.14K$11.79M$9.60M*$7.94M
2017-09-30-$13.79M-$17.00K$10.52M$2.74M*-$548.56K
2016-09-30-$23.08M-$34.22K$21.42M-$1.11M*-$2.81M
2015-09-30-$23.83M-$93.53K$21.15M-$2.79M
2014-09-30-$22.93M-$138.86K$28.43M$3.11M*$8.47M
2013-09-30-$13.55M-$132.76K$9.79M-$3.90M
2012-09-30-$12.19M-$133.60K$14.29M-$2.29M*-$319.55K
2011-09-30-$22.56M-$318.11K$3.94M-$3.37M*-$22.31M
2010-09-30-$12.80M-$503.94K$6.31M-$7.00M
2009-09-30-$6.51M$368.72K$2.20M$32.24M$4.56M*$32.86M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$4.03M*$0.00*$9.70M*-$1.03M*
2026-03-31-$4.02M*$0.00*$0.00*
2025-12-31-$4.02M$0.00$0.00-$653.77K*-$4.68M
2025-09-30-$4.67M*-$5.16K*$15.73M*-$1.89M*
2025-06-30-$3.94M*$0.00*$5.00M*-$1.19M*
2025-03-31-$4.37M*$0.00*$2.56M*-$880.23K*
2024-12-31-$4.14M-$32.95K$5.00M-$951.43K*-$124.06K
2024-09-30-$4.82M*-$19.75K*$10.85M*-$1.66M*
2024-06-30-$4.58M*-$23.47K*$0.00*
2024-03-31-$4.53M*$0.00*$7.75M*-$1.15M*
2023-12-31-$4.89M-$64.86K$4.98M-$931.51K*-$904.29K
2023-09-30-$5.04M*-$10.37K*$5.00M*-$934.20K*
2023-06-30-$5.67M*-$196.86K*$1.55M*-$600.93K*
2023-03-31-$7.47M*-$111.45K*$0.00*
2022-12-31-$4.67M-$53.58K$0.00-$4.65M
2022-09-30-$4.91M*-$16.07K*
2022-06-30-$5.79M*-$70.97K*$0.00*
2022-03-31-$2.73M*-$533.83K*
2021-12-31-$4.81M$6.11M$1.05M
2021-09-30-$4.80M*$4.59M*$0.00*$102.43K*
2021-06-30-$5.20M*-$2.00M*$60.92M*-$24.20M*$29.53M*
2021-03-31-$4.96M*-$14.62M*-$27.12M*$31.27M*-$15.43M*
2020-12-31-$3.83M-$3.15M$13.56M$6.35M
2020-09-30-$3.59M*-$1.12M*$0.00*-$4.63M*
2020-06-30-$3.70M*-$803.51K*$1.07M*$9.24M*$5.81M*
2020-03-31-$3.89M*-$657.08K*$7.87M*$1.62M*$4.95M*
2019-12-31-$4.10M-$109.71K$5.05M$938.60K
2019-09-30-$3.89M*-$49.04K*$0.00*$2.90M*-$1.04M*
2019-06-30-$4.64M*-$58.22K*$0.00*$8.67M*$3.97M*
2019-03-31-$3.63M*-$156.32K*$0.00*$2.62M*-$1.17M*
2018-12-31-$4.16M-$72.26K$0.00$601.90K*-$3.63M
2018-09-30-$4.24M*-$54.69K*$4.70M*$7.56M*$7.96M*
2018-06-30-$2.78M*-$2.34K*-$35.60K*$2.10M*-$715.54K*
2018-03-31-$3.75M*-$154.00*$4.70M*$919.46K*
2017-12-31-$2.61M-$959.00$2.42M-$226.70K
2017-09-30-$3.44M*-$6.48K*$3.35M*$1.23M*$1.14M*
2017-06-30-$3.13M*$0.00*$1.32M*$1.51M*-$297.32K*
2017-03-31-$2.99M*-$10.53K*$2.14M*-$856.87K*
2016-12-31-$4.24M$0.00$3.71M-$531.32K
2016-09-30-$6.86M*$2.19K*$4.56M*-$2.30M*
2016-06-30-$5.42M*-$14.77K*$4.60M*-$833.13K*
2016-03-31-$4.96M*-$6.81K*$1.71M*-$1.11M*-$4.37M*
2015-12-31-$5.84M-$14.83K$10.55M$4.70M
2015-09-30-$5.34M*-$27.49K*-$130.53K*-$5.50M*
2015-06-30-$6.25M*-$7.56K*$14.87M*$8.62M*
2015-03-31-$6.80M*-$41.37K*$0.00*-$6.85M*
2014-12-31-$5.44M-$17.10K$6.41M$947.62K
2014-09-30-$5.73M*-$38.69K*$0.00*-$5.77M*
2014-06-30-$6.02M*-$47.59K*$9.14M*$607.57K*$3.68M*
2014-03-31-$5.26M*-$44.00K*-$94.61K*$2.51M*-$2.89M*
2013-12-31-$5.92M-$8.59K$19.38M$13.45M
2013-09-30-$3.41M*-$14.90K*-$18.61K*-$3.44M*
2013-06-30-$3.47M*-$30.89K*$0.00*-$3.50M*
2013-03-31-$3.68M*-$70.75K*$0.00*-$3.75M*
2012-12-31-$2.99M-$16.22K$9.81M$6.80M
2012-09-30-$3.27M*-$11.41K*$0.00*-$3.28M*
2012-06-30-$3.13M*-$40.89K*$5.12M*$1.95M*
2012-03-31-$3.18M*-$64.52K*$5.36M*$1.81M*
2011-12-31-$2.61M-$16.77K$3.81M-$1.98M*-$798.37K
2011-09-30-$4.83M*-$118.59K*$3.94M*-$5.30M*-$6.32M*
2011-06-30-$7.18M*-$84.86K*-$1.41M*-$7.17M*
2011-03-31-$4.11M*-$84.93K*$1.41M*-$3.11M*
2010-12-31-$6.43M-$29.73K$0.00$749.79K*-$5.71M
2010-09-30-$3.74M*-$167.85K*$0.00*-$3.91M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Quince Therapeutics, Inc. (QNCX)United States$0.031B
aTYR PHARMA INC (ATYR)United States$0.033B-0.98
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
Scilex Holding Co (SCLX)United States$0.042B-0.14
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
BioCardia, Inc. (BCDA)United States$0.016B
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
Passage BIO, Inc. (PASG)United States$0.015B-0.43
LeonaBio, Inc. (LONA)United States$0.047B-0.61